Nan Niu Selected Research

Nan Niu Research Topics

Disease

12	Neoplasms (Cancer) 02/2024 - 01/2019
10	Adenocarcinoma 02/2024 - 01/2020
6	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2022
6	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 03/2020
4	Hypoxia (Hypoxemia) 11/2023 - 03/2019
2	Atherosclerosis 01/2024 - 08/2015
2	Triple Negative Breast Neoplasms 12/2023 - 01/2023
2	Myocardial Infarction 11/2023 - 08/2015
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2018 - 08/2016
2	Acute Coronary Syndrome 08/2016 - 08/2015
1	Bites and Stings (Sting) 11/2023
1	Breast Ductal Carcinoma 01/2023
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2023
1	Carotid Artery Diseases 01/2023
1	Atherosclerotic Plaque (Atheroma) 01/2023
1	Mastitis 01/2023
1	Neoplasm Metastasis (Metastasis) 11/2022
1	Cholangiocarcinoma 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2019
1	Inflammation (Inflammations) 01/2019
1	Coinfection 06/2016
1	Ataxia Telangiectasia (Louis Bar Syndrome) 05/2016
1	Laryngeal Neoplasms (Laryngeal Cancer) 05/2016
1	Pain (Aches) 04/2016
1	Hyperalgesia 04/2016

Drug/Important Bio-Agent (IBA)

3	Letrozole (Femara)FDA LinkGeneric 03/2024 - 11/2022
3	pyrotinibIBA 03/2024 - 11/2022
3	dalpiciclibIBA 03/2024 - 11/2022
3	Proteins (Proteins, Gene)FDA Link 05/2023 - 05/2016
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2020
3	InflammasomesIBA 01/2023 - 08/2015
2	Caspase 3 (Caspase-3)IBA 11/2023 - 08/2021
2	CytokinesIBA 11/2023 - 01/2022
2	Focal Adhesion Protein-Tyrosine KinasesIBA 11/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2020 - 03/2020
1	pertuzumabIBA 03/2024
1	Trastuzumab (Herceptin)FDA Link 03/2024
1	olaparibIBA 01/2024
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2023
1	ImmunosorbentsIBA 11/2023
1	Hematoxylin (Haematoxylon)IBA 11/2023
1	EnzymesIBA 11/2023
1	Indicators and Reagents (Reagents)IBA 05/2023
1	Estrogens (Estrogen)FDA Link 01/2023
1	Drug CombinationsIBA 01/2023
1	Tamoxifen FDA LinkGeneric 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Aldehyde Dehydrogenase 1 FamilyIBA 01/2023
1	Z 008IBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 11/2022
1	Hyaluronic Acid (Hyaluronan)IBA 11/2022
1	Programmed Cell Death 1 ReceptorIBA 11/2022
1	PEGPH20IBA 11/2022
1	AntigensIBA 10/2022
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 10/2022
1	ChromatinIBA 10/2022
1	Long Noncoding RNAIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Nuclear RNAIBA 01/2022
1	Granzymes (Granzyme)IBA 01/2022
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 08/2021
1	Matrix Metalloproteinases (MMPs)IBA 08/2021
1	Nuclear Respiratory Factor 1IBA 08/2021
1	Caspase 8 (Caspase-8)IBA 08/2021
1	CaspasesIBA 08/2021
1	Death Domain ReceptorsIBA 08/2021
1	Caspase 9IBA 08/2021
1	Cytochromes c (Cytochrome c)IBA 08/2021
1	Cancer VaccinesIBA 10/2020
1	IpilimumabIBA 10/2020
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 03/2020
1	InterferonsIBA 03/2020
1	VaccinesIBA 03/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	cobaltous chloride (cobalt(II)chloride)IBA 03/2019
1	Uric Acid (Urate)IBA 01/2019
1	Macrophage Migration-Inhibitory FactorsIBA 01/2019
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019
1	AngiotensinogenIBA 11/2018
1	Toll-Like Receptor 4IBA 11/2018
1	omega-Chloroacetophenone (Mace)IBA 08/2016
1	AntibodiesIBA 06/2016
1	Recombinant ProteinsIBA 06/2016
1	sodium glycididazoleIBA 05/2016
1	Fentanyl (Sublimaze)FDA LinkGeneric 04/2016

Therapy/Procedure

9	Therapeutics 11/2023 - 03/2020
4	Drug Therapy (Chemotherapy) 03/2024 - 03/2020
2	Radiotherapy 02/2024 - 01/2021
2	Immunotherapy 01/2022 - 03/2020
1	Neoadjuvant Therapy 03/2024
1	Radioimmunotherapy 02/2024
1	Mastectomy (Mammectomy) 01/2023
1	Adjuvant Chemotherapy 01/2022
1	Pancreaticoduodenectomy 01/2020